Answer
Efavirenz/Emtricitabine/Tenofovir disoproxil Glenmark is contraindicated with elbasvir/grazoprevir because co-administration may lead to loss of virologic response to elbasvir/grazoprevir.
Sources for this answer
- Efavirenz/Emtricitabine/Tenofovir disoproxil Glenmark 600 mg/ 200 mg/245 mg film-coated tabletsGlenmark Pharmaceuticals Europe Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 5Document updated
Sources checked